Figure 1
PFS, OS and complete response (CR) duration comparison between MS molecular subgroup and other subgroups in Total Therapy 3A and B trials.
Figure 1 | Leukemia
PFS, OS and complete response (CR) duration comparison between MS molecular subgroup and other subgroups in Total Therapy 3A and B trials.
